NOTE: Space is limited! Due to room capacity and catered dinner, in-person attendance will be capped at 60 people.
Pending Accreditation for 1 CEU. CEUs will be available for in-person or live virtual webinar attendance only!
When cancer therapy and cardiovascular health collide, timely recognition and management are critical.
This July, Margaret Sidsworth will lead a hybrid session at the University of British Columbia, exploring key cardio‑oncology challenges including cardiovascular risk, treatment‑related cardiotoxicity, and myocarditis.
By the end of this session, participants will be able to:
-
Identify cardiovascular risk in patients with cancer and apply prevention strategies
-
Recognize and manage fluoropyrimidine-associated cardiotoxicity
-
Optimize management of immune-checkpoint-inhibitor myocarditis
About Margaret Sidsworth, B.Sc Pharm, ACPR
As a graduate of University of British Columbia, Margaret has spent the past 16 years practicing in the Heart Function and Cardio-Oncology Clinic at Vancouver General Hospital. Alongside her clinical work, she am actively engaged in research, training, and knowledge translation, with a focus on advancing cardiovascular care in patients with cancer.